Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2011; 17(47): 5203-5213
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5203
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5203
Figure 1 IKK2 inhibitor prevented HF + LPS-induced liver injury, as determined by serum ALT and AST levels.
The normal values for ALT and AST were 45 U/L and 160 U/L. Serum ALT (A) and AST (B) were measured in different groups (control group, HF group, LPS-induced HF group and IMD-treated group), data are expressed as mean ± SD. A: aP < 0.05 vs control group, cP < 0.05 vs the HF and LPS + HF groups; B: bP < 0.01 vs the control group, eP < 0.05 vs the LPS + HF group. HF: High-fat; LPS: Lipopolysaccharide; IMD: IKK2 inhibitor; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.
- Citation: Wei J, Shi M, Wu WQ, Xu H, Wang T, Wang N, Ma JL, Wang YG. IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice. World J Gastroenterol 2011; 17(47): 5203-5213
- URL: https://www.wjgnet.com/1007-9327/full/v17/i47/5203.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i47.5203